Case analysis:
Rheumatoid arthritis (RA) and ankylosing spondylitis are autoimmune diseases which lead to self immune system disorders, and the patient has an inherited tendency also. In traditional therapy, doctors prefer to use NSAID, immunosuppressors, immunomodulators and steroids to control this kind of disease. In the early stages, these medications can be useful, but still had no use in some refractory cases. And these medications have very strong side effects, such as bone marrow suppression, drug-induced liver disease and infection post immune implantation.
In recent years, scientists have developed a new method for treating autoimmune disease with mesenchymal stem cells implantation. It has several advantages:
1. The mesenchymal stem cells can differentiate into immune cells, repair the immune system, some of them after implantation can repair and replace the damaged cells and tissue.
2. The mesenchymal stem cells can secrete different kinds of cell factors which can withhold inflammatory mediators and cells, repair damaged joints and the synovium, and block the development of the disease effectively.
3. There is no risk of a rejection reaction, it is safe and effective and the most important thing is that the stem cells treatment has a very measurable, positive effect.

Although stem cell treatment has positive effects for these autoimmune diseases, the patient still needs a comprehensive and systematic treatment plan. Traditional therapy still plays a very important role in our treatment procedure: the stem cells need a proper environment in order to grow better so that the general medications can adjust the internal environment, prevent the further damage to the bone joints structure, suppress the abnormal immune function, and actively treat for complications, in fact, traditional therapy is a vital factor in ensuring the overall success of the treatment results.